Radiotherapy and Oncology

Article	Citations
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor	147
PO-0244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up	112
The effect of delayed primary treatment initiation on adverse events and recurrence in older head and neck cancer patients	110
OC-0088 Reduced tube feeding dependence by continuous improvements in head and neck radiotherapy	100
FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection	93
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)	93
Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study	87
PO-1577 Evaluation of a new Automated TLD Reader for silica bead radiotherapy dosimetry	86
Contents	83
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma p	75
Study of upright patient positioning reproducibility in image-guided proton therapy for head and neck cancers	74
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	74
1861: Performance of a heart substructures autocontouring tool after clinical implementation	73
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	70
3201: Dosimetric properties of flexible 3D-printed boluses	66
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	66
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	61
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	61
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	60
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	58
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	57
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	56
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	55
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	51
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	50

3429: Modulating innate immunity by DNA damage response inhibition	50
749: Reinforcement learning for accelerated automatic treatment planning optimization	49
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	48
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	48
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	47
1635: In vivo dosimetry - keeping my finger on the pulse	46
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	45
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	45
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	45
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	45
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	43
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	43
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	42
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	41
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	40
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	40
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	40
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	39
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	39
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	39
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	38
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	38
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	38
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	38
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	37
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	37
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	37
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	35
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	35
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	35
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	34
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	34
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	33
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	33
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	33
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	33
3346: How to balance the patient and clinician needs: Are we on the same side?	33
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	33
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	33
1136: Electron beam radiotherapy for the management of perianal malignancies	33
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	33
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	32
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	32
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	32
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	32
3484: RAPTOR project: Verification	32
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	32
323: A comparison of 3D CNN architectures for monitoring ovarian cancer patients using PET/CT scans	31
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	31
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	31

3379: Management of older patients with skin cancer: Are we overtreating?	30
3548: Virtual patients for clinical trials	30
1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	30
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	29
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	29
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	29
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	29
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	29
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	29
MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy	28
Caffeic Acid Phenethyl Ester (CAPE), a natural polyphenol to increase the therapeutic window for lung adenocarcinomas	28
Balancing robustness and adaptation rate for proton therapy of lung cancer patients	28
Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis	27
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial	27
Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation	27
Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT	27
480 Addressing the education and training needs of RTT in particle radiation therapy	27
Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model	27
Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by Baiocchi et al	27
Clinical implementation of deep learning robust IMPT planning in oropharyngeal cancer patients: A blinded clinical study	27
Dosimetric benefit of a library of plans versus single-plan strategy for pre-operative gastric cancer radiotherapy	27
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	27
A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer	27
Intratumor genetic heterogeneity and head and neck cancer relapse	27
Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques	26
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	26
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	26
45 Stereotactic radiosurgery for tremor: a center experience.	26
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	26
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	26
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	26
525 Proton and carbon therapy: recent technological advances	26
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	26
529 Current standard of care treatment in non-metastatic cervix cancer	26
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	26
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	26
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	26
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	26
157 Adaptive radiation therapy	25
123 Can machine-learning model predict overall survival in head and neck cancer patients?	25
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	25
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	25
121 Differential functional outcomes following transoral surgery for oropharyngeal carcinoma -laser versus robot	25
95 Head and neck cancers with synchronous primary cancers in Ireland	24
PO-1759 Pre-treatment CBCT rotations as a predictor of intra-fraction motion in cranial SRS patients.	24
PO-1736 Using the DcmCollab Audit Tool to support quality assurance of clinical radiotherapy trials	24
PO-1743 Patient positioning and intrafraction movement control protocol using an IGRT and SGRT system in SRS	24
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	24
PH-0496 incidence and pattern of LRR in esophageal cancer patients treated with iCT followed by neoadj CTRT	23
PO-1929 Identification of DNA repair-based biomarkers related to treatment outcome in head and neck cancers	23
PO-1034 Hypofractionated Radiotherapy and Simultaneous Boost in radically inoperable cases with Glioblastoma	23
SP-0011 New developments In skin cancers treatment: is brachytherapy the new frontier especially for the face?	23
PO-1077 Population-based study on the association between autoimmune disease and lymphoma in Korea	23
PO-1084 Radiotherapy with simultaneous integrated boost for breast cancer: acute toxicity outcomes	23
PO-1617 Assessing the impact of treatment delivery uncertainty using DVHs	23
PO-1014 Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients	23
PO-1062 Stereotactic Radiosurgery for Brain Metastases from Renal Cell Carcinoma: A retrospective study	23
PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	23
PO-1061 Acces to radiation therapy in Lebanon: current status and challenges	23
SP-0014 Does work-place based assessment deliver on its promise?	23
PO-1655 Tuning deep learning models for automatic segmentation of head and neck cancers in PET/CT images	23
PO-1016 External validation of a nomogram for chemoirradiation in stage 2 nasopharyngeal carcinoma with IMRT	23
PO-1988 Designing a radiation therapy technologist training program for online adaptive Radiation Therapy	23
PO-1079 Do you use RT as part of bridging therapy for the treatment of DLBCL with CAR-T cells?	23
PO-1990 Remote RTT training in an international context during a global pandemic	23
PO-1113 A dosimetric comparison of two external beam radiotherapy techniques: 3DCRT & Tomotherapy in APBI	22
PO-1557 Automated Dose Monitoring On Target And Critical Organs Doses For Head And Neck Radiotherapy	22
SP-0024 Radiotherapy for vestibular schwannoma and meningioma	22
PO-1119 Internal Mammary Irradiation in breast cancer. Do CTV-PTV safety margins matter?	22
PD-0827 Development of target-optimized CBCT imaging to reduce imaging dose and improve image quality	22
SP-0371 Every physicist should also be a fully skilled data scientist	22
SP-0510 Physicist: Integration of imaging modalities in treatment planning	22
38: Radiation Therapy of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck – Insights from the Analysis of the BC Cancer Registry 2007-2017	22
OC-0634 Lymphocyte Sparing Radiation Therapy for stage III NSCLC: a dosimetric study	21
PO-1460 Adaptive re-planning with image guided pencil beam scanning proton beam therapy	21
Consistency in reirradiation scenarios: Terminology, tissue recovery in calculations, units and reporting	21
PO-1585 A fast and robust procedure for independent regular Linac output quantification	21
PO-1826 A tool to standardize plan quality in moderate hypofractionated prostate radiotherapy	21
PD-0804 Therapeutic use of Linac-based SRS in the treatment of malignant spasticity	21
OC-0647 Improved robustness in oesophageal cancer treatment by diaphragm based position verification	21

PO-1470 Fear is not a Barrier to Radiation Therapy in highly educated members of the public	21
PO-1603 One more image	21
PO-0944 Correlation on G8 score with sarcopenia is a prognostic factor for OS in patients with HNC	21
PO-1541 Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT	21
PO-1439 Clinical results of SBRT for spinal metastases using dedicated contouring/planning system	21
PD-0788 First results from the national network for quality assurance of MR images in RT in Denmark	21
PH-0265 Diaphragm motion prediction based on optical surface with machine learning for liver tumor SBRT	21
Letter to the editor regarding Shao et al., exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled	21
PH-0224 Association between the genomic immune response and locoregional control in ER- breast cancer	21
Distance to isocenter is not associated with an increased risk for local failure in LINAC-based single-isocenter SRS or SRT for multiple brain metastases	20
OC-0109 External validation of a prediction model for two-year mortality in esophageal cancer cohorts	20
OC-0111 Prognostic factors for isolated local recurrence after resection of pancreatic ductal adenocarcinoma	20
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	20
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	20
PO-1796 Dosimetric comparison of rectal dose reduction methods in brachytherapy for cervical cancer	20
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	20
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	20
PO-1835 A glimpse at breast internal mammary chain radiotherapy practice in the United Kingdom	20
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	20
174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	20
Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study	20
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	20
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	20
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	19
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	19
PO-2282 SABR Prostate: A review of specialised techniques for motion management	19
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	19
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	19
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	19
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	19
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	19
SP-0035 From atlas-based knowledge to ML-based planning solutions	19
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	19
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	19
MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer	18
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	18
PD-0733 Parameters influencing inter-Institute variability in KB plan prediction models for whole breast RT	18
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	18
PD-0230 Correlation between External and Internal Tumour Motion in Lung Stereotactic Ablative Radiotherapy	18
261 A 3D Star Shot to Determine Axes of Rotation	18
PO-1724 Dose-averaged LET may not be the best RBE-descriptor for proton therapy	18
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	18
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	18
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	18
PO-1779 Detection of mandibular osteoradionecrosis using novel imaging biomarkers for head and neck cancer	18
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	18
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	18
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	18
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	18
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	18
OC-0441 Risk of cardiac death increases with dose to cardiac sub structure avoidance region in lung cancer	17
PO-1873 Is auto-segmentation in prostate radiotherapy efficient and accurate?	17
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	17
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group	17
OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)	17
OC-0193 Introduction of IMPT for (N)SCLC patients: NTCP model based selection of patients and first results	17
OC-0428 Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers	17
Moderate adverse events and regional differences in CDK4/6 inhibitor treatment combined with palliative radiotherapy	17
PD-0240 Development of mid-treatment biological image guided adaptive radiotherapy (BIGART) for glioblastoma	17
OC-0187 Effects of proton vs photon irradiation on inflammation and senescence in salivary gland organoids	17
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	17
PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	17
OC-0432 Patterns of failure in oral cavity squamous cell carcinoma treated with adjuvant radiotherapy	17
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	17
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	17
OC-0282 Inhibition of oxidative phosphorylation alters the tumor microenvironment in syngeneic mouse models	17
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	17
OC-0426 ALDH genes as regulators of prostate cancer radioresistance, stemness and bone metastases	17
OC-0594 Head and Neck Squamous Cell Carcinoma derived CAFs alter their phenotype after ionizing radation	16
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	16
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	16
OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity	16
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	16
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	16
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	16
PD-0654 Surface Guided Radiotherapy accuracy vs tattoos position in 5- fractions breast radiotherapy.	16
SP-0013 Weekly contouring rounds and education movies to improve organ at risk delineation in neuro-oncology	16
OC-0592 Impact of palliative care referral on distress in patients undergoing RT for HNSCC: Randomized Trial	16
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	16
PO-1685 Creating clinically competitive FLASH proton therapy treatment plans	16
SP-0197 Status of brachytherapy education for brachytherapists and future needs in North America	16
MO-0721 Clinicogenomic predictors for the pattern of failure in high-grade glioma	16
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	16
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	16
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	16
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	16
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	16
PO-1674 Going from planar kV-MV to kV-kV setup images in image-guided radiotherapy of breast cancer	16
PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.	16
PO-1708 Application of dose accumulation for PTV margin design in MR-guided adaptive prostate SBRT	16
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	16
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	16
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	16
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	16
PO-1251 Perceived-health status in lung cancer survivors presenting long-term radiotherapy-related fatigue.	15